The Traderszone Network

Published in TZ Latest News 25 July, 2014 by The TZ Newswire Staff

Market Ignores AbbVie’s Impressive Sales Due To Reliance On Humira

By The Value Investor:

AbbVie (NYSE:ABBV) released a relatively strong set of second quarter results on Friday, yet shares lost some ground during the session.

read more